Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
Clinical trial NCT02784392 · COMPLETED
Trial details
- NCT number
- NCT02784392
- Sponsor
- Lyric Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.